Drawing for Serial No. 87978555

USPTO serial 87978555

Serial No. 87978555

Reviewed by CopyMark Law Group

Reg. 5603397Status 701Registered
Filing date
Status date
Registration date
Nov 6, 2018
Examiner
HESIK, APRIL ANNE
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with Serial No. 87978555?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

GABRIELLE S. ROTH

GABRIELLE S. ROTH Sughrue Mion, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000Washington, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
005Biological drugs for use in treating cancer [ , and autoimmunity ] ; therapeutic [ and medical diagnostic ] agents and preparations for use in therapies [ and diagnosis ] for cancer [ , and autoimmunity ] ; biochemicals, immunoglobulins and antigen-binding fragments for use in therapies [ and medical diagnosis ] for cancer [ , and autoimmunity ] ; therapeutic [ and diagnostic ] agents, preparations and substances for medical purposes for targeting application to immune system, cells [ , or genes ] ; immune modulators, immunoglobulin drug conjugates, immunotherapies and therapeutic [ and diagnostic ] agents, preparations and substances in the field of dysregulated proteolytic activity for medical purposes; immunotherapies and therapeutic [ and medical diagnostic ] agents, preparations and substances in the field of cancer [ , and autoimmunity ] for medical purposesACTIVEJul 19, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 24, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 24, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 24, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 24, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 13, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
May 13, 20258.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
May 13, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 23, 2024ES8RTEAS SECTION 8 RECEIVED—
Nov 6, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 30, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 30, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 21, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 21, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 16, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 6, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 2, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 1, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 18, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 18, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 17, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 17, 2018DPCCDIVISIONAL PROCESSING COMPLETE—
Sep 17, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 21, 2018IUAFUSE AMENDMENT FILED—
Aug 21, 2018DRRRDIVISIONAL REQUEST RECEIVED—
Aug 21, 2018ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 21, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 20, 2018EX1GSOU EXTENSION 1 GRANTED—
Aug 20, 2018EXT1SOU EXTENSION 1 FILED—
Aug 20, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 27, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 20, 2018CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Feb 16, 2018APETASSIGNED TO PETITION STAFF—
Feb 6, 2018EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Jan 2, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 2, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 13, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 26, 2017ALIEASSIGNED TO LIE—
Nov 14, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 14, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Nov 14, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 14, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 14, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 10, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 10, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 9, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 8, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 8, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 24, 2017GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jul 24, 2017GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jul 24, 2017EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Jul 24, 2017CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jul 17, 2017DOCKASSIGNED TO EXAMINER—
Jun 28, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jun 27, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 23, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance